Peptides in the Limelight: US FDA May Ease Restrictions on Several Peptides The Dermatology Digest Is BPC 157 Banned? Oral vs. Injectable Forms Explained FDA's Overreach on Compounded Peptides Peptide Therapy Vita 10 Therapy The FDA's new 503A update isn't the end of peptide therapy but it is a turning point. Several commonly used peptides are being re evaluated, with some removed from the restricted category